WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017185596) POLYHEXAMETHYLENE GUANIDINE MEDICAMENT FOR TREATING GASTROINTESTINAL DISEASES, METHOD FOR PREPARING SAME AND USE THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/185596 International Application No.: PCT/CN2016/099708
Publication Date: 02.11.2017 International Filing Date: 22.09.2016
IPC:
A61K 9/16 (2006.01) ,A61K 31/785 (2006.01) ,A61P 31/04 (2006.01) ,A61P 31/12 (2006.01) ,A61P 1/04 (2006.01) ,A61P 1/12 (2006.01)
Applicants: WEI, Guogang[CN/CN]; CN
Inventors: WEI, Guogang; CN
Agent: VALLEY OF SOFT BEIJING INTELLECTUAL PROPERTY AGENCY CO., LTD.; 105 Meters North of the Jingguang Railway East, Changyangyicun South, Changyang Town, Fangshan District Beijing 102455, CN
Priority Data:
201610261767.925.04.2016CN
Title (EN) POLYHEXAMETHYLENE GUANIDINE MEDICAMENT FOR TREATING GASTROINTESTINAL DISEASES, METHOD FOR PREPARING SAME AND USE THEREOF
(FR) MÉDICAMENT POLYHEXAMÉTHYLÈNE GUANIDINE DESTINÉ AU TRAITEMENT DES MALADIES GASTRO-INTESTINALES, PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
(ZH) 治疗肠胃疾病的聚六亚甲基胍药物及其制备方法和应用
Abstract:
(EN) The invention relates to a polyhexamethylene guanidine medicament for treating gastrointestinal diseases. The final polyhexamethylene guanidine medicament is prepared by using polyhexamethylene guanidine as an active component, and adding starch, glucose, lactose, microcrystalline cellulose and magnesium stearate in an appropriate weight ratio. The medicinal preparation can be used to treat the gastrointestinal diseases in human bodies in the form of a liquid, powder, particle, tablet or capsule.
(FR) La présente invention concerne un médicament polyhexaméthylène guanidine destiné au traitement des maladies gastro-intestinales. Le médicament polyhexaméthylène guanidine final est préparé à l'aide de la polyhexaméthylène guanidine comme composant actif, et en ajoutant de l’amidon, du glucose, du lactose, de la cellulose microcristalline et du stéarate de magnésium sous un rapport en poids approprié. La préparation médicinale peut être utilisée pour traiter les maladies gastro-intestinales dans les corps humains sous la forme d’un liquide, d’une poudre, d’une particule, d’un comprimé ou d’une capsule.
(ZH) 本发明涉及一种治疗肠胃疾病的聚六亚甲基胍药物,通过采用聚六亚甲基胍作为药效组分,并添加适合重量配比的淀粉、葡萄糖、乳糖、微晶纤维素和硬脂酸镁,最终制备得到聚六亚甲基胍药物,该药物制剂可以液体、粉剂、颗粒、片剂或胶囊剂形式治疗人体肠胃道疾病。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)